[1] Xiaohua Liu,Wan Sia Heng,Paul,et al.Novel polymeric microspheres containing norcantharidin for chemoembolization [ J] .Journal of Controlled release,2006,116(1):35-41. [2] 王广生,李荣昌,窦培延.去甲斑蝥素在胃肠液中的存在状态[J].中国药学杂志,1984,19(8):24-26. [3] 吴建梅,任天池.去甲斑蝥素脂质体的制备及理化性质研究[J].中国药学杂志,2005,40(19):1485-1489. [4] Yi-Chun Chen, Shi-Chuan Chang , Ming-Hsi Wu, et al. Norcantharidin reduced cyclins and cytokines production in human peripheral blood mononuclear cells[J]. Life Sciences,2009,84: 218-226. [5] Yu-Jen Chen,Wei-Min Chang, Yi-Wen Liu, et al. A small-molecule metastasis inhibitor, norcantharidin, downregulates matrix metalloproteinase-9 expression by inhibiting Sp1 transcriptional activity in colorectal cancer cells[J].Chemico-Biologica Interactions,2009, 181(3): 440-446. [6] Hui-Fen Liao,Yu-Jen Chen, Chin-Hung Chou, et al. Norcantharidin induces cell cycle arrest and inhibits progression of human leukemic Jurkat T cells through mitogen-activated protein kinase-mediated regulation of interleukin-2 production [J]. Toxicology inVitro,2011,25(1):206-212. [7] Chunmin Wei, Yanni Teng, Benjie Wang, et al. Separation and identification of norcantharidin metabolites in vivo by GC MS method[J]. Journal of Chromatography,2011,879 (20):1741-1747. [8] Qin Wang, Liang Zhang, Wei Hu, et al. Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery[J].Nanomedicine: Nanotechnology, Biology, and Medicine, 2010,6(2):371-381. |